We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCB icon
2826
PCB Bancorp
PCB
$400M
$74K ﹤0.01%
4,057
+2,901
+251% +$55.2K
PLTR icon
2827
Palantir
PLTR
$430B
$74K ﹤0.01%
9,093
-1,071
-11% -$9.52K
RDIB
2828
Reading International Class B
RDIB
$204M
$74K ﹤0.01%
3,962
+2,007
+103% +$44K
RYAN icon
2829
Ryan Specialty Holdings
RYAN
$11B
$74K ﹤0.01%
1,823
+1,409
+340% +$59.5K
SWTX
2830
DELISTED
SpringWorks Therapeutics
SWTX
$74K ﹤0.01%
2,590
-11,493
-82% -$330K
PETQ
2831
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$74K ﹤0.01%
10,637
+9,552
+880% +$129K
NGM
2832
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$74K ﹤0.01%
5,674
+3,441
+154% +$52.1K
SGFY
2833
DELISTED
Signify Health, Inc.
SGFY
$74K ﹤0.01%
2,533
+1,602
+172% +$36.9K
LFG
2834
DELISTED
Archaea Energy Inc.
LFG
$74K ﹤0.01%
4,112
-7
-0.2% -$123
ASPN icon
2835
Aspen Aerogels
ASPN
$510M
$73K ﹤0.01%
7,823
+3,583
+85% +$43.4K
BMRN icon
2836
BioMarin Pharmaceuticals
BMRN
$13.6B
$73K ﹤0.01%
855
-9,528
-92% -$848K
CLOV icon
2837
Clover Health Investments
CLOV
$2.41B
$73K ﹤0.01%
42,869
-67,686
-61% -$177K
CMTG icon
2838
Claros Mortgage Trust
CMTG
$262M
$73K ﹤0.01%
6,244
+363
+6% +$6.23K
FISI icon
2839
Financial Institutions
FISI
$825M
$73K ﹤0.01%
3,056
+2,216
+264% +$57.5K
FLIC
2840
DELISTED
First of Long Island Corp
FLIC
$73K ﹤0.01%
4,262
+3,041
+249% +$56.1K
KE
2841
Kimball Electronics
KE
$606M
$73K ﹤0.01%
4,251
+2,268
+114% +$46.2K
PUBM icon
2842
PubMatic
PUBM
$783M
$73K ﹤0.01%
4,405
+2,346
+114% +$42.4K
NSTG
2843
DELISTED
NanoString Technologies, Inc.
NSTG
$73K ﹤0.01%
5,705
+3,678
+181% +$51K
AL
2844
DELISTED
Air Lease Corp
AL
$72K ﹤0.01%
2,324
+371
+19% +$13.3K
ASR icon
2845
Grupo Aeroportuario del Sureste
ASR
$8.24B
$72K ﹤0.01%
367
-50
-12% -$10.2K
AVDL
2846
DELISTED
Avadel Pharmaceuticals
AVDL
$72K ﹤0.01%
14,364
+10,097
+237% +$55.6K
CLFD icon
2847
Clearfield
CLFD
$395M
$72K ﹤0.01%
690
+243
+54% +$23.6K
CLW icon
2848
Clearwater Paper
CLW
$356M
$72K ﹤0.01%
1,898
+1,372
+261% +$54.4K
NEXT icon
2849
NextDecade
NEXT
$1.8B
$72K ﹤0.01%
11,965
-15,063
-56% -$100K
PKOH icon
2850
Park-Ohio Holdings
PKOH
$716M
$72K ﹤0.01%
6,405
+5,515
+620% +$90.3K
112 113
114
115 116

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.